The earnings call presented a generally positive outlook, with strong revenue and bookings growth, significant AI-driven productivity improvements, and strategic advancements in AI capabilities. However, challenges in the Health Sciences segment and the impact of the U.S. Budget Bill on tax expenses were noted as concerns.

Company Guidance -

Q3 2025

During the Cognizant Technology Solutions Second Quarter 2025 Earnings Conference Call, the company reported robust financial performance metrics, highlighting a 7.2% year-over-year revenue growth in constant currency, reaching $5.2 billion. This marked the fourth consecutive quarter of year-over-year organic growth, driven primarily by Financial Services and Health Sciences sectors. Cognizant secured six large deals, including two mega deals each valued at approximately $1 billion, with total contract value (TCV) of large deals more than doubling year-over-year. Adjusted operating margin improved by 40 basis points to 15.6%, and headcount grew by 2% sequentially. Voluntary attrition for tech services fell by 60 basis points to 15.2%. The company emphasized its strategic focus on AI-led opportunities, noting that 30% of its code was AI-generated in Q2, up from 20% two quarters ago. Additionally, the company increased its full-year revenue growth guidance to 4% to 6% in constant currency, reflecting confidence from strong bookings, which grew 18% year-over-year.

Strong Revenue Growth

Second quarter revenue grew 7.2% year-over-year in constant currency to $5.2 billion, marking the fourth consecutive quarter of year-over-year organic growth.

Significant Bookings Increase

Q2 bookings grew 18% year-over-year, translating to trailing 12 months growth of 6%. The company landed 6 large deals with TCV of $100 million or greater, including 2 mega deals valued around $1 billion each.

AI-Driven Productivity Gains

Nearly 30% of the company's code was AI generated in Q2, up from approximately 20% two quarters ago, significantly improving developer productivity.

Adjusted Operating Margin Improvement

Adjusted operating margin improved to 15.6%, up by 40 basis points year-over-year.

Expansion of AI Capabilities

The company has over 2,500 early GenAI client engagements, a significant increase from 1,400 in Q1, and continues to invest in AI research and platform strategies.

Cognizant (CTSH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CTSH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	1.30 / -	1.25	―	―	―
Jul 30, 2025	2025 (Q2)	1.26 / 1.31	1.17	11.97% (+0.14)
Apr 30, 2025	2025 (Q1)	1.20 / 1.23	1.12	9.82% (+0.11)
Feb 05, 2025	2024 (Q4)	1.12 / 1.21	1.18	2.54% (+0.03)
Oct 30, 2024	2024 (Q3)	1.15 / 1.25	1.16	7.76% (+0.09)
Jul 31, 2024	2024 (Q2)	1.12 / 1.17	1.1	6.36% (+0.07)
May 01, 2024	2024 (Q1)	1.11 / 1.12	1.11	0.90% (+0.01)
Feb 06, 2024	2023 (Q4)	1.04 / 1.18	1.01	16.83% (+0.17)
Nov 01, 2023	2023 (Q3)	1.10 / 1.16	1.17	-0.85% (-0.01)
Aug 02, 2023	2023 (Q2)	0.99 / 1.10	1.14	-3.51% (-0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CTSH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$73.20	$71.44	-2.40%
Apr 30, 2025	$72.96	$74.61	+2.26%
Feb 05, 2025	$82.63	$86.08	+4.18%
Oct 30, 2024	$73.20	$73.44	+0.33%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.